1. Home
  2. FCBM vs OABI Comparison

FCBM vs OABI Comparison

Compare FCBM & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FCBM

First Carolina Financial Services Inc.

N/A

Current Price

$12.74

Market Cap

393.2M

Sector

N/A

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$2.13

Market Cap

391.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCBM
OABI
Founded
N/A
2012
Country
United States
Employees
N/A
89
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
393.2M
391.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FCBM
OABI
Price
$12.74
$2.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
106.8K
644.0K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$52.42
Revenue Next Year
N/A
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.50
$1.32
52 Week High
$13.40
$2.79

Technical Indicators

Market Signals
Indicator
FCBM
OABI
Relative Strength Index (RSI) 52.92 40.92
Support Level N/A $1.75
Resistance Level $12.99 $2.22
Average True Range (ATR) 0.33 0.18
MACD -0.02 -0.04
Stochastic Oscillator 26.67 9.17

Price Performance

Historical Comparison
FCBM
OABI

About FCBM First Carolina Financial Services Inc.

First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: